Page last updated: 2024-11-02

pioglitazone and Gastroduodenal Ulcer

pioglitazone has been researched along with Gastroduodenal Ulcer in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moustafa, YM1
El-Azab, MF1
Fouda, A1

Other Studies

1 other study available for pioglitazone and Gastroduodenal Ulcer

ArticleYear
15-PGDH inhibitors: the antiulcer effects of carbenoxolone, pioglitazone and verapamil in indomethacin induced peptic ulcer rats.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:15

    Topics: Animals; Anti-Ulcer Agents; Carbenoxolone; Gastric Acid; Gastric Mucosa; Hydroxyprostaglandin Dehydr

2013